|
Year to Dec 2025
12 months to Dec 31, 2025
|
Year to Dec 2024
12 months to Dec 31, 2024
|
Year to Dec 2023
12 months to Dec 31, 2023
|
Year to Dec 2022
12 months to Dec 31, 2022
|
Year to Dec 2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Impairment expense | |||||
| Depreciation and amortization expense | |||||
| Equity in income of joint ventures | |||||
| Stock-based compensation expense | |||||
| Changes in fair value of investments | |||||
| Elimination of unrealized profit on sales to joint ventures | |||||
| Debt issuance expense | |||||
| Gain on disposal of assets | |||||
| Deferred taxes | |||||
| Unrealized foreign exchange (gain) loss | |||||
| Changes in fair value of contingent consideration | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventories | |||||
| Other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Other liabilities | |||||
| Income taxes, net | |||||
| Dividends received from joint ventures | |||||
| Other | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Cash and cash equivalents and restricted cash acquired in the Merger | |||||
| Payment for acquired businesses, net of cash acquired | |||||
| Proceeds from settlement of contingent consideration | |||||
| Acquisition of technology | |||||
| Proceeds from disposal of assets | |||||
| Proceeds from sale / maturity of investments | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| (Cash pledged for) release of collateral deposits | |||||
| Payment of contingent consideration | |||||
| Payments of loan issuance and other transaction costs | |||||
| Proceeds from long-term borrowings | |||||
| Repayments of long-term borrowings | |||||
| Repurchase of common stock | |||||
| Payment of withholding taxes on stock-based compensation plans | |||||
| Repayment of financed insurance premium | |||||
| Repayments of finance leases | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) to cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash at beginning of year | |||||
| Cash and cash equivalents and restricted cash at end of year | |||||
Loading...